SU548046A1 - Diluent of lyophilized vaccine strain of madness virus - Google Patents

Diluent of lyophilized vaccine strain of madness virus

Info

Publication number
SU548046A1
SU548046A1 SU7402086351A SU2086351A SU548046A1 SU 548046 A1 SU548046 A1 SU 548046A1 SU 7402086351 A SU7402086351 A SU 7402086351A SU 2086351 A SU2086351 A SU 2086351A SU 548046 A1 SU548046 A1 SU 548046A1
Authority
SU
USSR - Soviet Union
Prior art keywords
strain
diluent
vaccines
virus
madness
Prior art date
Application number
SU7402086351A
Other languages
Russian (ru)
Inventor
К.Н. Бучнев
А.А. Росляков
И.Л. Квасов
В.А. Седов
Original Assignee
Buchnev K N
Roslyakov A A
Kvasov I L
Sedov V A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Buchnev K N, Roslyakov A A, Kvasov I L, Sedov V A filed Critical Buchnev K N
Priority to SU7402086351A priority Critical patent/SU548046A1/en
Application granted granted Critical
Publication of SU548046A1 publication Critical patent/SU548046A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Claims (2)

в другие вакцины и иные антигенные препа раты, в которых отсутствуют адънжанты, а препараты ввод т внутримышечно, напри дл  разбавлени  сухой BHpycBaKUHHbOHa штамма ЛТ против чумы крупного рогатого скота, сухой втфусвакцины из штамм против псевдочумы птиц, анатоксинных и бактериальных вакцин. .Формула изобретени  Разбавитель лиофилизированного вакцинного штамма вируса бешенства, отличающийс  тем, что, с целью сохранени  иммуногенных свойств штамма, разбавитель содержит сапонин, гидроокись алюмини , мертиолат и цитратно-фосфатный буфер при следуюшем соотношении компонентов , вес.%: Сапонин0,05-0,2 Гидроокись алюмини 10-25 Мертиолат0,01-0,025 Цитратно-фосфатный буфер Остальное. Источники информации, прин тые во внимание при экспертизе: 1. Назаров В. П. Бешенство животных, М., Сельхозгиз, 1961, с. 52. in other vaccines and other antigen preparations, in which adjuvants are absent, and the preparations are administered intramuscularly, for example, to dilute the dry LT strain of the BHpycBaKUHHbOHa strain against cattle plague, against the pseudo vaccines of birds, toxoids and bacterial vaccines. The formula of the invention is a diluent of a lyophilized rabies virus strain of a rabies virus, characterized in that, in order to preserve the immunogenic properties of the strain, the diluent contains saponin, aluminum hydroxide, merthiolate and citrate-phosphate buffer at the following ratio of components, wt.%: Saponin 0.05-0-0, 2 Aluminum hydroxide 10-25 Mertiolat0.01-0.025 Citrate phosphate buffer Else. Sources of information taken into account during the examination: 1. Nazarov V. P. Animal rabies, M., Selkhozgiz, 1961, p. 52. 2. Ветеринарное законодательство, т. 1, 1972, с. 535-536.2. Veterinary legislation, vol. 1, 1972, p. 535-536.
SU7402086351A 1974-12-13 1974-12-13 Diluent of lyophilized vaccine strain of madness virus SU548046A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU7402086351A SU548046A1 (en) 1974-12-13 1974-12-13 Diluent of lyophilized vaccine strain of madness virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU7402086351A SU548046A1 (en) 1974-12-13 1974-12-13 Diluent of lyophilized vaccine strain of madness virus

Publications (1)

Publication Number Publication Date
SU548046A1 true SU548046A1 (en) 1977-08-25

Family

ID=20604215

Family Applications (1)

Application Number Title Priority Date Filing Date
SU7402086351A SU548046A1 (en) 1974-12-13 1974-12-13 Diluent of lyophilized vaccine strain of madness virus

Country Status (1)

Country Link
SU (1) SU548046A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057540A (en) * 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057540A (en) * 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant

Similar Documents

Publication Publication Date Title
Casals et al. The complement fixation test in the diagnosis of virus infections of the central nervous system
Duff The oral immunization of trout against Bacterium salmonicida
Theiler et al. The use of yellow fever virus modified by in vitro cultivation for human immunization
EP0020356B1 (en) Pasteurellosis vaccines
JP3814290B2 (en) Adjuvant for antigen, production method and use thereof
BRPI0412444B1 (en) fraction of kilograms with low toxicity and its use
RU2010149495A (en) NEW ADJUVANT COMPOSITIONS
US4650677A (en) Method of preparing adjuvanted live attenuated vaccines and adjuvanted live attenuated vaccines thus obtained
JPH08325163A (en) Vaccine composition for mammal
GB1256456A (en) Ethylethyleneimine as inactivating agent in antigen-containing pharmaceutical preparations
CA1336406C (en) Bovine vaccine composition and method for preventing trichomas infection using same
GB1292803A (en) Improvements relating to the production of antigens
GB1256457A (en) Diethylaminoethyldextran (deae-d) as adjuvant for vaccines for active immunisation
EP0030063A2 (en) Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines, process for preventing infectious bronchitis and infectious-bronchitis virus strains
Zinkernagel Antiviral T-cell memory?
SU548046A1 (en) Diluent of lyophilized vaccine strain of madness virus
Archer et al. Effects of homologous and heterologous antiserum on neutralizing-antibody response to rabies vaccine
US2965544A (en) Tissue culture propagated canine distemper virus and vaccine thereof
Srivastava et al. The serological response of foals to vaccination against strangles.
US3000788A (en) Propagation of modified infectious canine hepatitis virus in tissue cultures of pig kidney and the preparation of a vaccine therefrom
GB1016586A (en) Vaccine for immunization of dogs against distemper and hepatitis contagiosa canis
US4328208A (en) Vaccine against chlamydous infections of farm animals
GB1152607A (en) Antigenic Compositions
Coggins et al. Serological Comparison with Rabbit Antisera of Hog Cholera Virus and Bovine Virus Diarrhea Virus.
Horgan et al. The immunological relationships of strains of alastrim virus